These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1603774)

  • 21. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin.
    Azoulay S; Adem C; Pelletier FL; Barete S; Francès C; Capron F
    J Cutan Pathol; 2005 Sep; 32(8):561-6. PubMed ID: 16115055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
    Pires Y; Andrade L; Cuello M; Chuaqui R
    Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic strategies for unknown primary cancer.
    Varadhachary GR; Abbruzzese JL; Lenzi R
    Cancer; 2004 May; 100(9):1776-85. PubMed ID: 15112256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological evaluation of neoplasms with unknown primary tumor site.
    Mackay B; Ordonez NG
    Semin Oncol; 1993 Jun; 20(3):206-28. PubMed ID: 8503017
    [No Abstract]   [Full Text] [Related]  

  • 26. [Metastases from unknown primary tumor].
    Hillen HF
    Ned Tijdschr Geneeskd; 1995 Nov; 139(44):2225-8. PubMed ID: 7501047
    [No Abstract]   [Full Text] [Related]  

  • 27. [The importance of immunohistochemistry in histological diagnosis].
    Hurlimann J
    Rev Med Suisse Romande; 1990 Jul; 110(7):597-602. PubMed ID: 2382067
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metastases of undetermined origin].
    Beauregard P; Mongeau CJ; Macle L
    Union Med Can; 1994 May; 123(5):296. PubMed ID: 8036725
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tumor markers--personal experience. Immunohistochemical markers for cancer diagnosis].
    Mukai K
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1383-8. PubMed ID: 2069409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodal neuroendocrine (Merkel cell) carcinoma without an identifiable primary tumor.
    Kuwabara H; Mori H; Uda H; Takei K; Ishibashi Y; Takatani N
    Acta Cytol; 2003; 47(3):515-7. PubMed ID: 12789943
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary lung cancer vs metastatic breast cancer: a probabilistic approach.
    Vollmer RT
    Am J Clin Pathol; 2009 Sep; 132(3):391-5. PubMed ID: 19687315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
    Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
    Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential diagnosis in immunohistochemistry with Bayes theorem.
    Vollmer RT
    Am J Clin Pathol; 2009 May; 131(5):723-30. PubMed ID: 19369634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Occult multicentric breast cancer].
    Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
    Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Edema and lymphadenopathy. 55-year-old patient with edema and lymphadenopathy: significance of fine needle biopsy. Metastatic large cell undifferentiated carcinoma of unknown primary tumor (pancreas, stomach, bronchial differential diagnosis)].
    Hirsch HH; Nüesch R
    Praxis (Bern 1994); 2001 Sep; 90(37):1597-9. PubMed ID: 11594126
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.
    Baker PM; Oliva E
    Int J Gynecol Pathol; 2005 Jan; 24(1):39-55. PubMed ID: 15626916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site.
    Bayer-Garner IB; Smoller B
    Mod Pathol; 2000 Feb; 13(2):119-22. PubMed ID: 10697267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.